Guardian Pharmacy Services, Inc. (NYSE:GRDN) reported second-quarter 2026 results and increased its financial guidance for the full year, sending shares up around 3.2% in premarket trading. The long-term care pharmacy provider pointed to continued operational momentum despite revenue growth being affected by pricing changes linked to the Inflation Reduction Act (IRA).
Revenue Grows as Company Lifts Full-Year Forecast
Guardian generated second-quarter revenue of $351.8 million, a 2% increase from $344.3 million in the same period last year.
The company raised its full-year 2026 revenue guidance to between $1.43 billion and $1.45 billion. The midpoint of $1.44 billion is above analysts’ consensus forecast of approximately $1.42 billion.
Management also increased its adjusted EBITDA outlook to a range of $129 million to $131 million, compared with its previous guidance of $122 million to $127 million.
Underlying Business Remains Strong
President and Chief Executive Officer Fred Burke said, “Guardian delivered another strong quarter, with continued momentum across our local markets.”
He added, “While IRA-related pricing reductions affected reported revenue growth, which was up 2%, the underlying business remained strong. Absent the price reductions from the IRA, revenues would have been up low double digits compared to the second quarter of 2025.”
Adjusted EBITDA rose to $29.7 million from $25.0 million a year earlier, reflecting continued improvement in operating performance.
Higher Profit and Expanding Customer Base
Guardian reported net income of $22.1 million, compared with $8.8 million in the second quarter of 2025. The latest figure included an $8.5 million settlement related to a payor dispute.
Diluted earnings per share were $0.34.
The number of residents served increased 8% year over year to approximately 210,000, highlighting continued customer growth across the business.
At the end of the quarter, the company held $89.8 million in cash and cash equivalents and had no outstanding long-term debt under its credit facility.
Leadership Changes Take Effect
Guardian also announced changes to its executive leadership team that became effective on 1 July 2026.
David Morris was appointed Chief Operating Officer, while Will Mudd assumed the role of Chief Financial Officer.
The combination of higher guidance, improved profitability and continued growth in residents served helped lift Guardian Pharmacy Services shares following the earnings announcement.
Guardian Pharmacy Services stock price
